The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vitafol Ultra
Doconexent, Niacinamide, .Alpha.-Tocopherol Acetate, DL-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, and Levomefolate Calcium · DOCONEXENT 200 mg/1; NIACINAMIDE 15 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; CHOLECALCIFEROL 25 ug/1; BETA CAROTENE 330 ug/1; ASCORBIC ACID 30 mg/1; THIAMINE MONONITRATE 1.6 mg/1; RIBOFLAVIN 1.8 mg/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; CYANOCOBALAMIN 12 ug/1; IRON 29 mg/1; ZINC OXIDE 25 mg/1; CUPRIC OXIDE 2 mg/1; POTASSIUM IODIDE 150 ug/1; MAGNESIUM OXIDE 20 mg/1; FOLIC ACID 680 ug/1; LEVOMEFOLATE CALCIUM 1020 ug/1 · Capsule, Liquid Filled · Oral · Exeltis USA, Inc.
NDC 00642-0093-03 · 1 BLISTER PACK in 1 BOX / 4 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for doconexent, niacinamide, .alpha.-tocopherol acetate, dl-, cholecalciferol, .beta.-carotene, ascorbic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, iron, zinc oxide, cupric oxide, potassium iodide, magnesium oxide, folic acid, and levomefolate calcium (oral solid) in the next 90 days
price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Doconexent, Niacinamide, .Alpha.-Tocopherol Acetate, DL-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, and Levomefolate Calcium (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Exeltis USA, Inc. | DOCONEXENT 200 mg/1; NIACINAMIDE 15 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; CHOLECALCIFEROL 25 ug/1; BETA CAROTENE 330 ug/1; ASCORBIC ACID 30 mg/1; THIAMINE MONONITRATE 1.6 mg/1; RIBOFLAVIN 1.8 mg/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; CYANOCOBALAMIN 12 ug/1; IRON 29 mg/1; ZINC OXIDE 25 mg/1; CUPRIC OXIDE 2 mg/1; POTASSIUM IODIDE 150 ug/1; MAGNESIUM OXIDE 20 mg/1; FOLIC ACID 680 ug/1; LEVOMEFOLATE CALCIUM 1020 ug/1 | Aug 26, 2026 | Sep 2, 2026 |
| Exeltis USA, Inc. | DOCONEXENT 9 mg/1; NIACINAMIDE 30 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 330 ug/1; CHOLECALCIFEROL 25 ug/1; BETA CAROTENE 2 mg/1; ASCORBIC ACID 12 ug/1; THIAMINE MONONITRATE 200 mg/1; RIBOFLAVIN 680 ug/1; PYRIDOXINE HYDROCHLORIDE 29 mg/1; CYANOCOBALAMIN 1020 ug/1; IRON 20 mg/1; ZINC OXIDE 15 mg/1; CUPRIC OXIDE 150 ug/1; POTASSIUM IODIDE 2.5 mg/1; MAGNESIUM OXIDE 1.8 mg/1; FOLIC ACID 1.6 mg/1; LEVOMEFOLATE CALCIUM 25 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Exeltis USA, Inc. | .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; ASCORBIC ACID 30 mg/1; BETA CAROTENE 330 ug/1; CHOLECALCIFEROL 25 ug/1; CUPRIC OXIDE 2 mg/1; CYANOCOBALAMIN 12 ug/1; DOCONEXENT 200 mg/1; FOLIC ACID 680 ug/1; IRON 29 mg/1; LEVOMEFOLATE CALCIUM 1020 ug/1; MAGNESIUM OXIDE 20 mg/1; NIACINAMIDE 15 mg/1; POTASSIUM IODIDE 150 ug/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; RIBOFLAVIN 1.8 mg/1; THIAMINE MONONITRATE 1.6 mg/1; ZINC OXIDE 25 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vitafol Ultra — NDC 00642-0093-03," retrieved September 3, 2026, https://drugdashboards.com/drug/00642009303.
Free to cite with attribution — see how the data is put together.